Effect of long-term piceatannol treatment on eNOS levels in cultured endothelial cells

Biochemical and Biophysical Research Communications

Volumn 430, Issue 3, 2013, Pages 1164-1168

  Kinoshita, Yosuke ^a   Kawakami, Shinpei ^a   Yanae, Koji ^a   Sano, Shoko ^a   Uchida, Hiroko ^a   Inagaki, Hiroyuki ^a   Ito, Tatsuhiko ^a  

^a Morinaga and Company Limited   (Japan)

Author keywords

Endothelium; ENOS; Piceatannol; Resveratrol; Vasorelaxation

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; PICEATANNOL; RESVERATROL;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

CELLS, CULTURED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; RNA, MESSENGER; STILBENES;

PASSIFLORA EDULIS; RATTUS;

EID: 84872499992     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.017     Document Type: Article

References (41)

1. Hirase T., Node K. Endothelial dysfunction as a cellular mechanism for vascular failure. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H499-505.
2. Hirata Y., Nagata D., Suzuki E., Nishimatsu H., Suzuki J., Nagai R. Diagnosis and treatment of endothelial dysfunction in cardiovascular disease. Int. Heart J. 2010, 51:1-6.
3. Kaplan N.M. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 1989, 149:1514-1520.
4. Stoclet J.C., Chataigneau T., Ndiaye M., Oak M.H., El Bedoui J., Chataigneau M., Schini-Kerth V.B. Vascular protection by dietary polyphenols. Eur. J. Pharmacol. 2004, 500:299-313.
5. Nijveldt R.J., van Nood E., van Hoorn D.E., Boelens P.G., van Norren K., van Leeuwen P.A. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 2001, 74:418-425.
6. Orallo F., Alvarez E., Camina M., Leiro J.M., Gomez E., Fernandez P. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol. Pharmacol. 2002, 61:294-302.
7. Toda N., Toda H. Coronary hemodynamic regulation by nitric oxide in experimental animals: recent advances. Eur. J. Pharmacol. 2011, 667:41-49.
8. Geller D.A., Billiar T.R. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev. 1998, 17:7-23.
9. Hoffmann J., Haendeler J., Aicher A., Rossig L., Vasa M., Zeiher A.M., Dimmeler S. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ. Res. 2001, 89:709-715.
10. Matsushita H., Chang E., Glassford A.J., Cooke J.P., Chiu C.P., Tsao P.S. ENOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Circ. Res. 2001, 89:793-798.
11. MacAllister R.J., Parry H., Kimoto M., Ogawa T., Russell R.J., Hodson H., Whitley G.S., Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol. 1996, 119:1533-1540.
12. Forstermann U., Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006, 113:1708-1714.
13. Cannon R.O. Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin. Chem. 1998, 44:1809-1819.
14. Giraldez R.R., Panda A., Xia Y., Sanders S.P., Zweier J.L. Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart. J. Biol. Chem. 1997, 272:21420-21426.
15. Nicholson S.K., Tucker G.A., Brameld J.M. Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. Br. J. Nutr. 2010, 103:1398-1403.
16. Steffen Y., Schewe T., Sies H. (-)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem. Biophys. Res. Commun. 2007, 359:828-833.
17. Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., Forstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002, 106:1652-1658.
18. Wallerath T., Li H., Godtel-Ambrust U., Schwarz P.M., Forstermann U. A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 2005, 12:97-104.
19. Matsui Y., Sugiyama K., Kamei M., Takahashi T., Suzuki T., Katagata Y., Ito T. Extract of passion fruit (Passiflora edulis) seed containing high amounts of piceatannol inhibits melanogenesis and promotes collagen synthesis. J. Agric. Food Chem. 2010, 58:11112-11118.
20. Piotrowska H., Kucinska M., Murias M. Biological activity of piceatannol: leaving the shadow of resveratrol. Mutat. Res. 2012, 750:60-82.
21. Lee S.K., Mbwambo Z.H., Chung H., Luyengi L., Gamez E.J., Mehta R.G., Kinghorn A.D., Pezzuto J.M. Evaluation of the antioxidant potential of natural products. Comb. Chem. High Throughput Screen 1998, 1:35-46.
22. Larrosa M., Tomas-Barberan F.A., Espin J.C. Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells. J. Agric. Food Chem. 2003, 51:4576-4584.
23. Kedzierski L., Curtis J.M., Kaminska M., Jodynis-Liebert J., Murias M. In vitro antileishmanial activity of resveratrol and its hydroxylated analogues against leishmania major promastigotes and amastigotes. Parasitol. Res. 2007, 102:91-97.
24. Docherty J.J., McEwen H.A., Sweet T.J., Bailey E., Booth T.D. Resveratrol inhibition of Propionibacterium acnes. J. Antimicrob. Chemother. 2007, 59:1182-1184.
25. Gerhauser C., Klimo K., Heiss E., Neumann I., Gamal-Eldeen A., Knauft J., Liu G.Y., Sitthimonchai S., Frank N. Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat. Res. 2003, 523-524:163-172.
26. Niles R.M., Cook C.P., Meadows G.G., Fu Y.M., McLaughlin J.L., Rankin G.O. Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth. J. Nutr. 2006, 136:2542-2546.
27. Sano S., Sugiyama K., Ito T., Katano Y., Ishihata A. Identification of the strong vasorelaxing substance scirpusin B, a dimer of piceatannol, from passion fruit (Passiflora edulis) seeds. J. Agric. Food Chem. 2011, 59:6209-6213.
28. Li H.F., Tian Z.F., Qiu X.Q., Wu J.X., Zhang P., Jia Z.J. A study of mechanisms involved in vasodilatation induced by resveratrol in isolated porcine coronary artery. Physiol. Res. 2006, 55:365-372.
29. Rakici O., Kiziltepe U., Coskun B., Aslamaci S., Akar F. Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. Int. J. Cardiol. 2005, 105:209-215.
30. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399:597-601.
31. Woodman C.R., Price E.M., Laughlin M.H. Aging induces muscle-specific impairment of endothelium-dependent dilation in skeletal muscle feed arteries. J. Appl. Physiol. 2002, 93:1685-1690.
32. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605.
33. Lantin-Hermoso R.L., Rosenfeld C.R., Yuhanna I.S., German Z., Chen Z., Shaul P.W. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am. J. Physiol. 1997, 273:L119-L126.
34. Kim F., Gallis B., Corson M.A. TNF-alpha inhibits flow and insulin signaling leading to NO production in aortic endothelial cells. Am. J. Physiol. Cell Physiol. 2001, 280:C1057-C1065.
35. Roupe K., Teng X.W., Fu X., Meadows G.G., Davies N.M. Determination of piceatannol in rat serum and liver microsomes: pharmacokinetics and phase I and II biotransformation. Biomed. Chromatogr. 2004, 18:486-491.
36. Zhang Q.J., Wang Z., Chen H.Z., Zhou S., Zheng W., Liu G., Wei Y.S., Cai H., Liu D.P., Liang C.C. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc. Res. 2008, 80:191-199.
37. Csiszar A., Labinskyy N., Pinto J.T., Ballabh P., Zhang H., Losonczy G., Pearson K., de Cabo R., Pacher P., Zhang C., Ungvari Z. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H13-20.
38. Kahyo T., Ichikawa S., Hatanaka T., Yamada M.K., Setou M. A novel chalcone polyphenol inhibits the deacetylase activity of SIRT1 and cell growth in HEK293T cells. J. Pharmacol. Sci. 2008, 108:364-371.
39. Maggiolini M., Recchia A.G., Bonofiglio D., Catalano S., Vivacqua A., Carpino A., Rago V., Rossi R., Ando S. The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells. J. Mol. Endocrinol. 2005, 35:269-281.
40. Wober J., Moller F., Richter T., Unger C., Weigt C., Jandausch A., Zierau O., Rettenberger R., Kaszkin-Bettag M., Vollmer G. Activation of estrogen receptor-beta by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds. J. Steroid Biochem. Mol. Biol. 2007, 107:191-201.
41. Gehm B.D., McAndrews J.M., Chien P.Y., Jameson J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 1997, 94:14138-14143.